603079 Zhejiang Shengda Bio-Pharm
- 11.91
- +0.12+1.02%
Zhejiang Shengda Bio-Pharm News
Beijing Deheng Law Firm\'s Supplementary Legal Opinion on Zhejiang Shengda Biopharmaceutical Co., Ltd.\'s issuance of A-shares to specific targets in 2023 (3)
Issuance letter from CITIC Construction Investment Securities Co., Ltd. regarding the issuance of shares by Zhejiang Shengda Biopharmaceutical Co., Ltd. to specific targets
CITIC Construction Investment Securities Co., Ltd. listing sponsorship for Zhejiang Shengda Biopharmaceutical Co., Ltd. to issue shares to specific targets
Zhejiang Shengda Biopharmaceutical Co., Ltd. Prospectus for Issuing Stock Securities to Specific Targets (Application Draft) (2024 Semi-Annual Financial Data Update)
Announcement of Zhejiang Shengda Bio-Pharmaceutical Co., Ltd. regarding the change of the purpose of repurchasing shares.
Zhejiang Shengda Bio-Pharm Co., Ltd. Announcement on the Implementation of Annual Equity Distribution in 2023.
Zhejiang Shengda Biopharmaceutical Co., Ltd. Prospectus for Issuing Stock Securities to Specific Targets (Application Draft) (2023 Financial Data Update)
CITIC Construction Investment Securities Co., Ltd. listing sponsorship for Zhejiang Shengda Biopharmaceutical Co., Ltd. to issue shares to specific targets
Issuance letter from CITIC Construction Investment Securities Co., Ltd. regarding the issuance of shares by Zhejiang Shengda Biopharmaceutical Co., Ltd. to specific targets
Beijing Deheng Law Firm's Supplementary Legal Opinion on Zhejiang Shengda Biopharmaceutical Co., Ltd.'s issuance of A-shares to specific targets in 2023 (2)
Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on the implementation results of share repurchase and share changes
Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on the company's 2023 profit distribution plan
Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on the progress of repurchase of shares through centralized bidding
Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on the progress of repurchase of shares through centralized bidding
Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on the issuance of A shares to specific targets in 2023, diluted immediate returns and compensation measures and related subjects' commitments (revised draft)
Zhejiang Shengda Biopharmaceutical Co., Ltd.'s plan to issue A-shares to specific targets in 2023 (revised draft)
Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on adjusting the plan to issue A-shares to specific targets
Feasibility analysis report on the use of capital raised by Zhejiang Shengda Biopharmaceutical Co., Ltd. by issuing A-shares to specific targets in 2023 (revised draft)
Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on the revised plan to issue A-shares to specific targets in 2023
Demonstration analysis report on Zhejiang Shengda Biopharmaceutical Co., Ltd.'s 2023 A-share issuance plan to specific targets (revised draft)
Analysis
Price Target
No Data
No Data